Anvisa approves the vaccine for children aged 6 months to 4 years

(*4*)

Photo: Freepik

The National Health Agency (Anvisa) has accepted the enlargement of the use of Pfizer’s Covid-19 vaccine in children aged 6 months to 4 years. According to the company, the authorization permits instant use of the immunizer for this age group in Brazil, however the determination to introduce and set up a calendar for this group will likely be made by the Ministry of Health.

According to Anvisa, the approval was obtained after a technical evaluation of information and scientific research performed by the laboratory. According to the company’s technical staff, the evaluated information present that the vaccine is protected and efficient for children 6 months to 4 years of age.

A latest paper, “Vaccination of children towards Covid-19” by the Infectious Diseases Scientific Division (DC) of the São Paulo Pediatric Society (SPSP) was written by Silvia Bardella Marano and Eitan Berezin, member and president respectively. The SPSP Center for Infectious Diseases reviewed the results of Covid-19 on children and warned about the significance of vaccination, in addition to explaining the security and effectiveness of vaccines.

The doc factors out that the highest variety of deaths are in the 1-4 age group, adopted by children aged 5-9 years, indicating the pressing want for vaccination in these age teams. Although not all nations report Covid-19 deaths by age group, information collected by UNICEF in 91 nations by June 2022 reveals that Covid-19 was the main explanation for loss of life in 5,376 children beneath 5 years of age. . Unfortunately, Brazil accounts for 1 in 5 of those deaths.

The textual content additionally emphasizes that sick children, even delicate ones, put different folks, together with adults, whether or not they’re dad and mom, academics, aunts or grandparents, liable to problems, hospitalization and loss of life. Therefore, the most secure means to shield the complete inhabitants is vaccination. As for the security of vaccines, there are already 1000’s of printed research on children worldwide, which present that after vaccination, neutralizing antibody responses at concentrations related to these noticed in adolescents and adults can be found, and there may be scientific proof to assist their security. effectiveness of vaccination in stopping extreme instances, problems and hospitalization.

The SPSP acknowledges that the advantages of vaccination towards Covid-19 in the pediatric inhabitants outweigh the potential dangers related to vaccination in the present pandemic. As such, the Paulista Pediatric Society helps youngster and adolescent vaccination with out restriction and is absolutely assured that, primarily based on scientific proof, ANVISA-approved and licensed vaccines are protected and efficient, lowering hospitalizations, sequelae, and deaths. with the illness in children and adolescents. (Flávia Lo Bello – Vérité Comunicação – SPSP press workplace – e-mail: [email protected])

Leave a Comment

Your email address will not be published.